Substance Use Disorder: Treatment And Alternative Approaches To Pain Management Part II
This program requires the completion advance online home study component (Part I) prior to attending the live programming component (Part II).
You must attend the full session and complete a post-test evaluation in order to receive credit. This program has been co-developed with the Pennsylvania Pharmacists Association.
At the completion of this activity, the participant will be able to:
- Review opioid equianalgesic conversions/rotation process.
- Describe current CDC chronic pain management opioid prescribing guidelines.
- Discuss opioid discontinuation/tapering methodology.
- Describe process of patient-specific opioid and adjunctive medication selection.
- Develop care plans for patients utilizing a variety of approaches for pain management including non-opioid and non-pharmacologic modalities.
- Discuss the differences between naloxone delivery devices.
- Demonstrate how to appropriately assemble the naloxone atomizer.
- Demonstrate how to appropriately administer naloxone via a simulated overdose response.
- Discuss effective methods to engage patients about naloxone.
- Develop a treatment plan for the management of a patient with OUD in the ED.
- Develop a treatment plan for a patient with OUD who is being discharged from the ED.
- Discuss management of acute substance-induced agitation.
- Given a patient scenario, recommend optimal management for a patient with alcohol use disorder.
- Participate in a mock AA meeting.
- Consider the concept of anonymity as it relates to recovery.
- Define the key concepts of Cognitive Behavioral Therapy. Describe how Cognitive Behavioral Therapy works.
- Identify the differences between the components of Cognitive Behavioral Therapy.
- Describe the induction and chronic care management of OUD using buprenorphine-containing medications.
- Develop a plan for addressing recurrence of substance use with your patient.
- Develop a plan for OUD treatment using methadone.
- Discuss the pros and cons of using buprenorphine or methadone for the treatment of OUD.
- Discuss monitoring parameters for OUD treatment with buprenorphine and methadone.
- Define the principle of harm reduction.
- Describe harm reduction strategies that are commonly employed to minimize negative consequences of substance use.
- Debate the pros and cons of harm reduction strategies.
The Pennsylvania Pharmacists Association is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
Activity Type: Application-based
Contact Hours: 7 (0.7 CEU)
Release Date: 6/28/2021
Expiration Date: 6/28/2024
Target Audience: Pharmacists